Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

10/05/2024 07:30

May 10 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2024        Mar 31, 2023     Dec 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.38                1.17             6.80     
                 (+18.0 pct)         (+87.8 pct)      (+11.1 pct) 
  Operating        214 mln          loss 155 mln        410 mln   
  Recurring        229 mln          loss 242 mln        360 mln   
  Net              472 mln          loss 243 mln        550 mln   
  EPS             9.41 yen          loss 5.59 yen      10.97 yen  
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T